ITEMS IN AFP WITH KEYWORD:
Oral and Dental Conditions
A patient presented with a nonhealing wound on the jaw.
Many adverse drug events present intra- or periorally in isolation or as a clinical symptom. Clinical recognition and treatment of adverse drug events are important to manage drug therapy or to detect early signs of serious outcomes. Oral manifestations of commonly prescribed medications include gingival enlargement, oral hyperpigmentation, oral hypersensitivity reaction, medication-related osteonecrosis, and xerostomia. Physicians should prescribe medications using the lowest effective dose with minimal duration. Oral adverse drug events can be managed several ways, including oral hygiene instructions and medication substitution.
A child presented with a painful, round, erythematous lesion on the gingiva of the left upper gum above the canine tooth.
At the turn of the millennium, the U.S. Surgeon General declared dental disease a silent epidemic. A careful oral examination reveals information about numerous systemic conditions, from nutritional deficiencies to infections and cancer.
A man presented with a solitary erythematous nodule on his chin that had persisted for three months despite antibiotic treatment.
A woman presented with lesions on her tongue, as well as bare patches with raised erythematous borders.
May 1, 2016 Issue
Fluoride Varnish for Preventing Dental Caries in Children and Adolescents [Cochrane for Clinicians]
Topically applied fluoride varnishes are safe and effective in preventing dental caries in children and adolescents. There is little information about adverse effects or treatment acceptability. Family physicians should consider incorporating fluoride varnish into childhood preventive care visits.
Fluoride is an important aspect of good oral care. With 181 million Americans not visiting the dentist annually, family physicians have an essential role in oral health care.
Mar 15, 2015 Issue
Screening for Oral Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.